High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma

被引:58
|
作者
Yoshimoto, T.
Matsuura, K.
Karnan, S.
Tagawa, H.
Nakada, C.
Tanigawa, M.
Tsukamoto, Y.
Uchida, T.
Kashima, K.
Akizuki, S.
Takeuchi, I.
Sato, F.
Mimata, H.
Seto, M.
Moriyama, M.
机构
[1] Oita Univ, Dept Mol Pathol, Fac Med, Oita 87011, Japan
[2] Oita Univ, Dept Urol, Fac Med, Oita 87011, Japan
[3] Aichi Canc Ctr, Div Mol Med, Nagoya, Aichi 464, Japan
[4] Oita Univ, Div Biomol Med & Med Imaging, Oita 87011, Japan
[5] Oita Univ Hosp, Pathol Ctr, Oita, Japan
[6] Shin Beppu Hosp, Dept Pathol, Oita, Japan
[7] Mie Univ, Grad Sch Engn, Div Comp Sci, Tsu, Mie, Japan
关键词
renal cell carcinoma; clear cell carcinoma; array CGH; gene expression; oligonucleotide microarray;
D O I
10.1002/path.2239
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We analysed chromosomal copy number aberrations (CNAs) in renal cell carcinomas by array-based comparative genomic hybridization, using a genome-wide scanning array with 2304 BAC and PAC clones covering the whole human genome at a resolution of roughly 1.3 Mb. A total of 30 samples of renal cell carcinoma were analysed, including 26 cases of clear cell carcinoma (CCC) and four cases of chromophobe renal cell carcinoma (ChCC). In CCCs, gains of chromosomes 5q33.1-qter (58%), 7q11.22-q35 (35%) and 16p12.3-p13.12 (19%), and losses of chromosomes 3p25.1-p25.3 (77%), 3p21.31-p22.3 (81%), 3p14.1-p14.2 (77%), 8p23.3 (31%), 9q21.13-qter (19%) and 14q32.32-qter (38%) were detected. On the other hand, the patterns of CNAs differed markedly between CCCs and ChCCs. Next, we examined the correlation of CNAs with expression profiles in the same tumour samples in 22/26 cases of CCC, using oligonucleotide microarray. We extracted genes that were differentially expressed between cases with and without CNAs, and found that significantly more up-regulated genes were localized on chromosomes 5 and 7, where recurrent genomic gains have been detected. Conversely, significantly more down-regulated genes were localized on chromosomes 14 and 3, where recurrent genomic losses have been detected. These results revealed that CNAs were correlated with deregulation of gene expression in CCCs. Furthermore, we compared the patterns of genomic imbalance with histopathological features, and found that loss of 14q appeared to be a specific and additional genetic abnormality in high-grade CCC. When we compared the expression profiles of low-grade CCCs with those of high-grade CCCs, differentially down-regulated genes tended to be localized on chromosomes 14 and 9. Thus, it is suggested that copy number loss at 14q in high-grade CCC may be involved in the down-regulation of genes located in this region. Copyright (c) 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:392 / 401
页数:10
相关论文
共 50 条
  • [1] High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas
    Maria V Yusenko
    Roland P Kuiper
    Tamas Boethe
    Börje Ljungberg
    Ad Geurts van Kessel
    Gyula Kovacs
    BMC Cancer, 9
  • [2] Copy Number Alterations with Prognostic Potential in Clear Cell Renal Cell Carcinoma
    Maruschke, Matthias
    Koczan, Dirk
    Ziems, Bjoern
    Hakenberg, OliverW.
    UROLOGIA INTERNATIONALIS, 2018, 101 (04) : 417 - 424
  • [3] High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: Impact of copy number on gene expression
    Wolf, M
    Mousses, S
    Hautaniemi, S
    Karhu, R
    Huusko, P
    Allinen, M
    Elkahloun, A
    Monni, O
    Chen, YD
    Kallioniemi, A
    Kallioniemi, OP
    NEOPLASIA, 2004, 6 (03): : 240 - 247
  • [4] High-resolution analysis of DNA copy number alterations in rectal cancer Correlation with metastasis, survival, and mRNA expression
    Doyen, Jerome
    Letouze, Eric
    Marisa, Laetitia
    de Reynies, Aurelien
    Milano, Gerard
    Etienne-Grimaldi, Marie-Christine
    Olschwang, Sylviane
    Gaedcke, Jochen
    Ghadimi, Michael
    Gerard, Jean-Pierre
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (11) : 1028 - 1036
  • [5] High-resolution analysis of copy number alterations and associated expression changes in ovarian tumors
    Haverty, Peter M.
    Hon, Lawrence S.
    Kaminker, Joshua S.
    Chant, John
    Zhang, Zemin
    BMC MEDICAL GENOMICS, 2009, 2
  • [6] Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer
    Tsukamoto, Y.
    Uchida, T.
    Kaman, S.
    Noguchi, T.
    Nguyen, L. T.
    Tanigawa, M.
    Takeuchi, I.
    Matsuura, K.
    Hijiya, N.
    Nakada, C.
    Kishida, T.
    Kawahara, K.
    Ito, H.
    Murakami, K.
    Fujioka, T.
    Seto, M.
    Moriyama, M.
    JOURNAL OF PATHOLOGY, 2008, 216 (04) : 471 - 482
  • [7] Gene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma
    Fisher, Kevin E.
    Yin-Goen, Qiqin
    Alexis, Dianne
    Sirintrapun, Joseph S.
    Harrison, William
    Isett, R. Benjamin
    Rossi, Michael R.
    Moreno, Carlos S.
    Young, Andrew N.
    Osunkoya, Adeboye O.
    MODERN PATHOLOGY, 2014, 27 (02) : 222 - 230
  • [8] Gene expression profiling of renal cell carcinoma: a DNA macroarray analysis
    Lovisolo, Jon A. J.
    Casati, Barbara
    Clerici, Libero
    Marafante, Erminio
    Bono, Aldo V.
    Celato, Nicola
    Salvadore, Maurizio
    BJU INTERNATIONAL, 2006, 98 (01) : 205 - 216
  • [9] Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management
    Maruschke, Matthias
    Reuter, D.
    Koczan, D.
    Hakenberg, O. W.
    Thiesen, H. -J.
    BJU INTERNATIONAL, 2011, 108 (2B) : E29 - E35
  • [10] Use of microgenomic technology for analysis of alterations in DNA copy number and gene expression in malignant melanoma
    Trent, JM
    Bittner, MH
    Zhang, J
    Wiltshire, R
    Ray, M
    Su, Y
    Gracia, E
    Meltzer, P
    DeRisi, J
    Penland, L
    Brown, P
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 107 : 33 - 40